Research ArticleArticle
Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada
Andrea M. Knight, Michelle E. Vickery, Eyal Muscal, Alaina M. Davis, Julia G. Harris, Arzu Soybilgic, Karen B. Onel, Laura E. Schanberg, Tamar Rubinstein, Beth S. Gottlieb, David S. Mandell and Emily von Scheven
The Journal of Rheumatology April 2016, jrheum.151228; DOI: https://doi.org/10.3899/jrheum.151228
Andrea M. Knight
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Michelle E. Vickery
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Eyal Muscal
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Alaina M. Davis
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Julia G. Harris
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Arzu Soybilgic
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Karen B. Onel
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Laura E. Schanberg
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Tamar Rubinstein
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Beth S. Gottlieb
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
David S. Mandell
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Emily von Scheven
From the Division of Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the Children’s Hospital of Philadelphia (CHOP); Perelman School of Medicine, and Center for Mental Health Policy and Services Research, University of Pennsylvania, Philadelphia, Pennsylvania; Baylor College of Medicine; Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, Houston, Texas; Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital, Nashville, Tennessee; Division of Rheumatology, Children’s Mercy Kansas City; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri; Division of Pediatric Rheumatology, University of Illinois at Chicago; University of Illinois Hospital and Health Sciences System; Division of Pediatric Rheumatology, University of Chicago; University of Chicago Medicine, Chicago, Illinois; Division of Pediatric Rheumatology, Duke University Medical Center; Duke School of Medicine, Durham, North Carolina; Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, New York; The Hofstra North Shore-LIJ School of Medicine, Hempstead; Clinical and Translational Sciences Institute, Rochester, New York; Division of Pediatric Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA. Funded by the Children’s Hospital of Philadelphia. A.M. Knight, MD, MSCE, Attending Physician, Faculty, Division of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP, and Assistant Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania; M.E. Vickery, MPH, Center for Pediatric Clinical Effectiveness, and PolicyLab at the CHOP; E. Muscal, MD, MS, Attending Physician, Department of Pediatric Medicine, Division of Immunology, Allergy and Rheumatology, Texas Children’s Hospital, and Director, Assistant Professor of Pediatrics, Fellowship Program in Pediatric Rheumatology, Baylor College of Medicine; A.M. Davis, MD, Clinical Fellow, Division of Pediatric Rheumatology, Vanderbilt University School of Medicine, Monroe Carell Junior Children’s Hospital; J.G. Harris, MD, Attending Physician, Division of Rheumatology, Children’s Mercy Kansas City, and Assistant Professor of Pediatrics, Kansas City School of Medicine, University of Missouri; A. Soybilgic, MD, Attending Physician, University of Illinois Hospital and Health Sciences System, and Assistant Professor of Clinical Pediatrics, Division of Pediatric Rheumatology, University of Illinois at Chicago; K.B. Onel, MD, Section Chief, Pediatric Rheumatology, Division of Pediatrics, University of Chicago, and Associate Professor of Pediatrics, University of Chicago Medicine; L.E. Schanberg, MD, Co-chief, Division of Pediatric Rheumatology, Duke University Medical Center, and Professor of Pediatrics, Duke School of Medicine; T. Rubinstein, MD, MS, Fellow, Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children’s Hospital at Montefiore; B.S. Gottlieb, MD, MS, Division Chief, Division of Pediatric Rheumatology, Cohen Children’s Medical Center of New York, and Associate Professor, The Hofstra North Shore-LIJ School of Medicine; D.S. Mandell, ScD, Director, Center for Mental Health Policy and Services Research, University of Pennsylvania, and Associate Director, Center for Autism Research, the CHOP, and Associate Professor of Psychiatry and Pediatrics, Perelman School of Medicine, University of Pennsylvania; E. von Scheven, MD, MAS, Chief, Division of Pediatric Rheumatology, University of California San Francisco Medical Center, and Co-director for Residency Research Training, Clinical and Translational Sciences Institute, and Professor of Clinical Pediatrics, University of California San Francisco School of Medicine. Address correspondence to Dr. A. Knight, Division of Rheumatology, The Children’s Hospital of Philadelphia, 3535 Market St., Ste. 1527, Philadelphia, Pennsylvania 19104, USA. E-mail: knightan@email.chop.edu. Accepted for publication February 12, 2016.
Roles: for the CARRA Investigators
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada
Andrea M. Knight, Michelle E. Vickery, Eyal Muscal, Alaina M. Davis, Julia G. Harris, Arzu Soybilgic, Karen B. Onel, Laura E. Schanberg, Tamar Rubinstein, Beth S. Gottlieb, David S. Mandell, Emily von Scheven
The Journal of Rheumatology Apr 2016, jrheum.151228; DOI: 10.3899/jrheum.151228
Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada
Andrea M. Knight, Michelle E. Vickery, Eyal Muscal, Alaina M. Davis, Julia G. Harris, Arzu Soybilgic, Karen B. Onel, Laura E. Schanberg, Tamar Rubinstein, Beth S. Gottlieb, David S. Mandell, Emily von Scheven
The Journal of Rheumatology Apr 2016, jrheum.151228; DOI: 10.3899/jrheum.151228